Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
The business activities of Enzo Biochem are performed by the company�s three wholly owned subsidiaries . . . Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. Such activities include research and development, manufacturing and marketing of biomedical research products and tools through Enzo Life Sciences and research and development of therapeutic products through Enzo Therapeutics and the operation of a regional clinical reference laboratory through Enzo Clinical Labs.
Enzo Biochem, Inc. reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.
The Company’s financial condition remained strong, with working capital of $42.1 million. As of October 31, 2010, cash and cash equivalents, plus short term investments in US Treasury Bills, totaled $31.6 million. At November 30, 2010 Enzo�s cash, and cash equivalents and short-term investments were $33.9 million, which exceeded the July 31, 2010 balance by $0.3 million. Cash utilization in operations declined year over year by approximately $1 million to $1.8 million principally due to the reduced loss in the 2011 period. Management�s plan is to move towards being cash flow positive from operations in calendar 2011. There was no debt.
Power3 Medical Products, Inc. (OTC.BB:PWRM) a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. The company�s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer�s disease, and Parkinson�s disease.
Soon after skin cancer, cancer of the breast is easily the most widespread cancers recognized in females in the United States. But breast cancer rates now have fallen in recent times, and medical professionals are not certain of the reason why. Even now, for numerous women of all ages, breast cancer could be the condition they will fear most.
Alzheimer�s has no current cure, nonetheless treatments designed for conditions are available and research continues. Even though most current Alzheimer treatments can�t eliminate Alzheimer�s disease from progressing, they�re able to temporarily impede the worsening connected with symptoms as well as advance well being for anyone with Alzheimer�s not to mention all their caregivers. Today, there exists a world-wide exertion under way to find better ways to take care of the disease, delay its onset, and forestall it from evolving.
Parkinson�s disease (PD) is part of several disorders called motor system disorders, that are the effect of the decline of dopamine-producing brain cells. Some primary symptoms of PD tend to be tremor, or shaking in hands, arms, legs, jaw, and face; stiffness, as well as tightness of the limbs and trunk; bradykinesia, or slowness to move; and postural instability, or impaired equilibrium and also balance. As far as symptoms become more pronounced, patients sometimes have challenges walking, talking, or finishing some other rather simple tasks.
Zhongpin, Inc. (Nasdaq:HOGS) announced on December 13, 2010 that it would build a new production, research & development, test, and training complex in its home city of Changge in Henan province of China.The new facility will add 100,000 metric tons of capacity for prepared pork products, including Chinese-style, western-style, half-cooked, and easy-to-cook pork products. Adjacent to the production facility will be a new center for advanced research & development, test, training, and other support functions.
Zhongpin Inc., through its subsidiaries, engages in the processing and distribution of meat and food products primarily in the People’s Republic of China. It offers pork and pork products, such as chilled pork, frozen pork, pig by-products and variety meats, and prepared meats; and fruits and vegetables, which include asparagus, sweet corn, broccoli, mushrooms, lima beans, strawberries, and capsicum.
Rambus Inc. (Nasdaq:RMBS) updated on December 06, 2010, its guidance for the quarter ending December 31, 2010. As a result of the patent license agreement with Elpida announced earlier, the Company revised its revenue guidance for the quarter to be between $85 million and $93 million. Rambus initially provided revenue guidance for the quarter in the range of $40 million and $50 million.
Rambus Inc. designs, develops, and licenses chip interface technologies and architectures that are used in digital electronics products. Its products include Dual Edge Clocking, which is designed to allow data to be sent on the clock pulse; Variable Burst Length that improves data transfer efficiency by allowing varying amounts of data to be sent per a memory read or write request in dynamic random access memory (DRAM) and flash memory; and FlexPhase technology, which synchronizes data output and compensates for circuit timing errors.
Harbin Electric, Inc. (Nasdaq:HRBN) announced that the Company has launched the production of a new model of in-house developed specialty micro-motors for one-touch automatic car trunk opening at its new manufacturing facility in Shanghai supplying Shanghai General Motors (�Shanghai GM�) through Magna International (China).After more than two years of research and development efforts with this product, the Company obtained production approval in October and officially launched production after one month of preparation and tests.
Harbin Electric, Inc., through its subsidiaries, engages in the design, development, manufacture, supply, and service of electric motors in the People’s Republic of China and internationally. The company’s product lines include linear motors and integrated systems, automobile specialty micro-motors, and industrial rotary motors. Its linear motors and integrated systems comprise flat linear asynchronous motor series and flat three-phase linear asynchronous motors, which are applied in transmission systems.
No comments:
Post a Comment